ITCI - Intra-Cellular Therapies, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ITCI (1567514)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
54 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2024-08-29
ITCIMates SharonCOB, CEOS - Sale+OE$72.70-70,0001,070,329-6%-$5,089,236
DM
2024-08-26
ITCIMates SharonCOB, CEOS - Sale+OE$73.54-95,9251,070,329-8%-$7,054,085
DM
2024-08-21
ITCIMates SharonCOB, CEOS - Sale+OE$75.05-121,0731,070,329-10%-$9,086,738
D
2024-08-16
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale+OE$75.08-18,71429,700-39%-$1,405,047
D
2024-06-24
ITCIRiggs Rory BDirS - Sale+OE$75.57-4,462116,600-4%-$337,193
D
2024-06-18
ITCIVan Nostrand Robert LDirS - Sale+OE$75.91-20,0009,690-67%-$1,518,199
DM
2024-03-07
ITCIMates SharonCOB, Pres, CEOS - Sale+OE$66.07-61,2771,050,309-6%-$4,048,400
DM
2024-03-07
ITCIHineline Lawrence J.SVP of Finance, CFOS - Sale+OE$66.32-23,2530-100%-$1,542,147
DM
2024-03-07
ITCIHalstead MichaelEVP, GCS - Sale+OE$66.09-20,4770-100%-$1,353,235
DM
2024-03-07
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale+OE$66.23-20,47729,700-41%-$1,356,110
DM
2024-03-07
ITCIDurgam Suresh K.EVP, Chief Medical OfficerS - Sale+OE$66.21-10,16219,803-34%-$672,791
D
2024-02-27
ITCIVan Nostrand Robert LDirS - Sale+OE$72.93-20,0009,611-68%-$1,458,650
D
2024-02-26
ITCIHalstead MichaelEVP, GCS - Sale+OE$69.53-7,9070-100%-$549,784
D
2024-02-26
ITCIHineline Lawrence J.SVP of Finance, CFOS - Sale+OE$69.43-13,3370-100%-$925,961
D
2024-02-26
ITCIMates SharonCOB, Pres, CEOS - Sale+OE$69.79-22,5901,050,309-2%-$1,576,464
D
2024-02-26
ITCIDurgam Suresh K.EVP, Chief Medical OfficerS - Sale+OE$70.17-4,1129,488-30%-$288,534
D
2024-02-26
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale+OE$70.13-7,90729,700-21%-$554,491
D
2024-02-26
ITCIMarcus Joel SDirS - Sale+OE$68.68-26,32849,662-35%-$1,808,253
2024-02-02
ITCIHalstead MichaelEVP, GCS - Sale$66.42-11,8600-100%-$787,719
2024-02-02
ITCIMates SharonCOB, Pres, CEOS - Sale$67.07-33,8851,050,309-3%-$2,272,694
2024-02-02
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale$67.15-11,86029,700-29%-$796,367
2024-02-02
ITCIHineline Lawrence J.SVP of Finance, CFOS - Sale$66.62-11,1830-100%-$745,037
2024-02-02
ITCIDurgam Suresh K.EVP, Chief Medical OfficerS - Sale$67.19-6,1675,693-52%-$414,355
DM
2024-01-16
ITCIMates SharonCOB, Pres, CEOS - Sale+OE$66.27-191,3621,050,309-15%-$12,680,892
D
2024-01-11
ITCIHalstead MichaelEVP, GCS - Sale+OE$66.83-50,0000-100%-$3,341,699
D
2024-01-02
ITCIDurgam Suresh K.EVP, Chief Medical OfficerS - Sale+OE$70.60-62,2820-100%-$4,397,113
2023-12-13
ITCIDurgam Suresh K.EVP, Chief Medical OfficerS - Sale$65.00-21,2620-100%-$1,382,030
D
2023-11-06
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale+OE$55.63-42,39329,700-59%-$2,358,152
M
2023-09-18
ITCIMates SharonCOB, Pres, CEOS - Sale$53.94-100,0001,050,309-9%-$5,394,065
D
2023-08-07
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale+OE$58.79-55,30045,339-55%-$3,251,087
2023-07-17
ITCIDurgam Suresh K.EVP, Chief Medical OfficerS - Sale$65.00-1,84221,262-8%-$119,730
D
2023-06-14
ITCIHineline Lawrence J.SVP of Finance CFOS - Sale+OE$63.97-81,8540-100%-$5,236,329
D
2023-04-17
ITCIVan Nostrand Robert LDirS - Sale+OE$63.00-10,0009,345-52%-$630,000
2023-03-28
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale$54.31-15,60445,339-26%-$847,380
D
2023-03-13
ITCIDurgam Suresh K.EVP, Chief Medical OfficerS - Sale+OE$45.04-7,34423,104-24%-$330,794
DM
2023-03-10
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale+OE$43.84-12,30860,943-17%-$539,599
DM
2023-03-10
ITCIHalstead MichaelEVP, GCS - Sale+OE$43.66-24,0520-100%-$1,050,092
DM
2023-03-10
ITCIHineline Lawrence J.SVP of Finance CFOS - Sale+OE$43.55-21,2450-100%-$925,225
DM
2023-03-10
ITCIMates SharonCOB, Pres, CEOS - Sale+OE$43.76-62,3351,150,309-5%-$2,727,841
2023-03-01
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale$50.01-7,24149,199-13%-$362,122
D
2023-02-24
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale+OE$47.12-4,04656,440-7%-$190,648
D
2023-02-24
ITCIDurgam Suresh K.SVP, Chief Medical OfficerS - Sale+OE$47.14-7,90623,104-25%-$372,689
D
2023-02-24
ITCIHalstead MichaelEVP, GCS - Sale+OE$47.03-7,9060-100%-$371,819
D
2023-02-24
ITCIHineline Lawrence J.SVP of Finance CFOS - Sale+OE$47.03-7,4550-100%-$350,609
D
2023-02-24
ITCIMates SharonCOB, Pres, CEOS - Sale+OE$47.03-22,5901,130,309-2%-$1,062,408
D
2023-02-21
ITCINeumann MarkEVP, Chief Commercial OfficerS - Sale+OE$47.01-3,89852,580-7%-$183,246
D
2023-02-21
ITCIDurgam Suresh K.SVP, Chief Medical OfficerS - Sale+OE$46.84-8,35423,104-27%-$391,304
D
2023-02-21
ITCIHalstead MichaelEVP, GCS - Sale+OE$46.84-11,1390-100%-$521,699
DM
2023-02-17
ITCIHineline Lawrence J.SVP of Finance CFOS - Sale+OE$49.34-64,4110-100%-$3,178,354
D
2023-02-21
ITCIMates SharonCOB, Pres, CEOS - Sale+OE$46.83-27,8481,100,309-2%-$1,304,000
2022-12-19
ITCIMarcus Joel SDirS - Sale$50.82-5,00039,233-11%-$254,100
2022-12-13
ITCIMates SharonCOB, Pres, CEOS - Sale$55.00-33,0831,100,309-3%-$1,819,565
D
2022-12-01
ITCIHalstead MichaelEVP, GCS - Sale+OE$53.73-50,0000-100%-$2,686,514
2022-11-07
ITCIMarcus Joel SDirS - Sale$52.30-10,00044,233-18%-$523,023

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top